Biomarkers · Metabolic
Serum Citrate
Lower values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
Serum Citrate and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
Published risk of death1.33×per 1-SD increment in plasma citrate (NMR) (95% CI 1.21–1.45) · Random subset of the Estonian Biobank, age 18-103 y (replicated in a Finnish population cohort, n=7,503)
Sources
- Risk curve: Fischer 2014 (PMID 24586121): all-cause HR 1.33 (1.21-1.45) per 1-SD increment in plasma citrate (NMR). Scaled to published population values.
- Fischer et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS medicine. 2014;11:e1001606.
Map Serum Citrate against another biomarker.
Related markers: Homocysteine